Brother Enterprises HoldingLtd Past Earnings Performance
Past criteria checks 0/6
Brother Enterprises HoldingLtd has been growing earnings at an average annual rate of 9.2%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 19.7% per year.
Key information
9.2%
Earnings growth rate
11.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 19.7% |
| Return on equity | -7.0% |
| Net Margin | -7.1% |
| Next Earnings Update | 30 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Brother Enterprises HoldingLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,965 | -211 | 217 | 161 |
| 31 Dec 23 | 2,821 | -175 | 225 | 134 |
| 30 Sep 23 | 2,918 | 34 | 198 | 127 |
| 30 Jun 23 | 3,070 | 120 | 230 | 126 |
| 31 Mar 23 | 3,208 | 213 | 247 | 124 |
| 01 Jan 23 | 3,411 | 306 | 245 | 141 |
| 30 Sep 22 | 3,479 | 300 | 275 | 145 |
| 30 Jun 22 | 3,257 | 267 | 256 | 139 |
| 31 Mar 22 | 2,923 | 120 | 215 | 134 |
| 31 Dec 21 | 2,733 | 28 | 219 | 116 |
| 30 Sep 21 | 2,404 | -71 | 181 | 90 |
| 30 Jun 21 | 2,249 | -52 | 169 | 76 |
| 31 Mar 21 | 2,150 | 19 | 219 | 71 |
| 31 Dec 20 | 1,919 | 28 | 249 | 70 |
| 30 Sep 20 | 1,780 | 126 | 308 | 73 |
| 30 Jun 20 | 1,585 | 116 | 331 | 76 |
| 31 Mar 20 | 1,404 | 89 | 281 | 71 |
| 31 Dec 19 | 1,258 | 44 | 241 | 70 |
| 30 Sep 19 | 1,239 | -34 | 210 | 69 |
| 30 Jun 19 | 1,283 | -64 | 185 | 72 |
| 31 Mar 19 | 1,308 | -76 | 174 | 77 |
| 31 Dec 18 | 1,415 | 22 | 169 | 78 |
| 30 Sep 18 | 1,560 | 228 | 161 | 77 |
| 30 Jun 18 | 1,670 | 334 | 137 | 100 |
| 31 Mar 18 | 1,697 | 410 | 164 | 82 |
| 31 Dec 17 | 1,565 | 403 | 178 | 66 |
| 30 Sep 17 | 1,404 | 321 | 217 | 43 |
| 30 Jun 17 | 1,209 | 255 | 240 | 0 |
| 31 Mar 17 | 1,084 | 200 | 204 | 0 |
| 31 Dec 16 | 1,063 | 168 | 179 | 0 |
| 30 Sep 16 | 1,009 | 132 | 139 | 0 |
| 30 Jun 16 | 1,001 | 118 | 122 | 0 |
| 31 Mar 16 | 987 | 103 | 120 | 0 |
| 31 Dec 15 | 905 | 82 | 113 | 0 |
| 30 Sep 15 | 847 | 61 | 102 | 0 |
| 30 Jun 15 | 837 | 59 | 99 | 0 |
| 31 Mar 15 | 804 | 50 | 92 | 0 |
| 31 Dec 14 | 801 | 40 | 95 | 0 |
| 30 Sep 14 | 790 | 38 | 95 | 0 |
| 30 Jun 14 | 774 | 33 | 98 | 0 |
| 31 Mar 14 | 777 | 35 | 89 | 0 |
| 31 Dec 13 | 784 | 18 | 81 | 0 |
| 30 Sep 13 | 770 | -66 | 88 | 0 |
| 30 Jun 13 | 761 | -78 | 77 | 0 |
Quality Earnings: 002562 is currently unprofitable.
Growing Profit Margin: 002562 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002562 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.2% per year.
Accelerating Growth: Unable to compare 002562's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002562 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.4%).
Return on Equity
High ROE: 002562 has a negative Return on Equity (-6.99%), as it is currently unprofitable.